Search Results

There are 983 results for: content related to: Comparison of Pioglitazone vs Glyburide in Early Heart Failure: Insights From a Randomized Controlled Study of Patients With Type 2 Diabetes and Mild Cardiac Disease

  1. Greater reductions in A1C in type 2 diabetic patients new to therapy with glyburide/metformin tablets as compared to glyburide co-administered with metformin

    Diabetes, Obesity and Metabolism

    Volume 5, Issue 6, November 2003, Pages: 424–431, L. Blonde, J. Wogen, C. Kreilick and A. A. Seymour

    Version of Record online : 6 NOV 2003, DOI: 10.1046/j.1463-1326.2003.00297.x

  2. Improving glyburide solubility and dissolution by complexation with hydroxybutenyl-β-cyclodextrin

    Journal of Pharmacy and Pharmacology

    Volume 61, Issue 1, January 2009, Pages: 23–30, Sandra Klein, Michael F. Wempe, Thomas Zoeller, Norma L. Buchanan, Juanelle L. Lambert, Michael G. Ramsey, Kevin J. Edgar and Charles M. Buchanan

    Version of Record online : 8 JAN 2010, DOI: 10.1211/jpp.61.01.0004

  3. Glyburide Inhibits Dipyridamole-induced Forearm Vasodilation but not Adenosine-induced Forearm Vasodilation

    Clinical Pharmacology & Therapeutics

    Volume 75, Issue 3, March 2004, Pages: 147–156, Peter Bijlstra, Egidia E. M. van Ginneken, Marc Huls, Rob van Dijk, Paul Smits and Gerard A. Rongen

    Version of Record online : 9 MAR 2004, DOI: 10.1016/j.clpt.2003.09.016

  4. You have free access to this content
    Sitagliptin, an dipeptidyl peptidase-4 inhibitor, does not alter the pharmacokinetics of the sulphonylurea, glyburide, in healthy subjects

    British Journal of Clinical Pharmacology

    Volume 66, Issue 1, July 2008, Pages: 36–42, Goutam C. Mistry, Arthur J. Bergman, Wei Zheng, David Hreniuk, Miguel A. Zinny, Keith M. Gottesdiener, John A. Wagner, Gary A. Herman and Marcella Ruddy

    Version of Record online : 22 MAY 2008, DOI: 10.1111/j.1365-2125.2008.03148.x

  5. Glyburide/metformin combination product is safe and efficacious in patients with type 2 diabetes failing sulphonylurea therapy

    Diabetes, Obesity and Metabolism

    Volume 4, Issue 6, November 2002, Pages: 368–375, L Blonde, J Rosenstock, A. D. Mooradian, B-A. Piper and D. Henry

    Version of Record online : 30 OCT 2002, DOI: 10.1046/j.1463-1326.2002.00229.x

  6. You have full text access to this OnlineOpen article
    Saxagliptin added to a submaximal dose of sulphonylurea improves glycaemic control compared with uptitration of sulphonylurea in patients with type 2 diabetes: a randomised controlled trial

    International Journal of Clinical Practice

    Volume 63, Issue 9, September 2009, Pages: 1395–1406, A. R. Chacra, G. H. Tan, A. Apanovitch, S. Ravichandran, J. List, R. Chen and for the CV181-040 Investigators

    Version of Record online : 15 JUL 2009, DOI: 10.1111/j.1742-1241.2009.02143.x

    Corrected by:


    Vol. 64, Issue 2, 277, Version of Record online: 11 DEC 2009

  7. Simultaneous glyburide/metformin therapy is superior to component monotherapy as an initial pharmacological treatment for type 2 diabetes

    Diabetes, Obesity and Metabolism

    Volume 4, Issue 3, May 2002, Pages: 201–208, A. J. Garber, J. Larsen, S. H. Schneider, B. A. Piper, D. Henry and The Glyburide/Metformin Initial Therapy Study Group

    Version of Record online : 30 MAY 2002, DOI: 10.1046/j.1463-1326.2002.00211.x

  8. Elucidating Rifampin's Inducing and Inhibiting Effects on Glyburide Pharmacokinetics and Blood Glucose in Healthy Volunteers: Unmasking the Differential Effects of Enzyme Induction and Transporter Inhibition for a Drug and Its Primary Metabolite

    Clinical Pharmacology & Therapeutics

    Volume 85, Issue 1, January 2009, Pages: 78–85, HX Zheng, Y Huang, LA Frassetto and LZ Benet

    Version of Record online : 8 OCT 2008, DOI: 10.1038/clpt.2008.186

  9. You have free access to this content
    Glyburide as treatment option for gestational diabetes mellitus

    Journal of Obstetrics and Gynaecology Research

    Volume 39, Issue 6, June 2013, Pages: 1147–1152, Anjali Tempe and Ronita Devi Mayanglambam

    Version of Record online : 30 MAY 2013, DOI: 10.1111/jog.12042

  10. CYP2C9, but not CYP2C19, polymorphisms affect the pharmacokinetics and pharmacodynamics of glyburide in Chinese subjects

    Clinical Pharmacology & Therapeutics

    Volume 78, Issue 4, October 2005, Pages: 370–377, Ophelia Q.P. Yin, Brian Tomlinson and Moses S.S. Chow

    Version of Record online : 5 OCT 2005, DOI: 10.1016/j.clpt.2005.06.006

  11. Glyburide decreases myocardial oxygen pressure in dogs

    Acta Anaesthesiologica Scandinavica

    Volume 47, Issue 2, February 2003, Pages: 221–225, W. E. Hoffman, R. F. Albrecht Jr and Z. S. Jonjev

    Version of Record online : 7 MAR 2003, DOI: 10.1034/j.1399-6576.2003.00039.x

  12. Pharmacokinetic and Pharmacodynamic Interaction of Boswellic Acids and Andrographolide with Glyburide in Diabetic Rats: Including Its PK/PD Modeling

    Phytotherapy Research

    Volume 30, Issue 3, March 2016, Pages: 496–502, Sujatha Samala and Ciddi Veeresham

    Version of Record online : 13 JAN 2016, DOI: 10.1002/ptr.5556

  13. You have free access to this content
    Pharmacoepidemiologic and in vitro evaluation of potential drug–drug interactions of sulfonylureas with fibrates and statins

    British Journal of Clinical Pharmacology

    Volume 78, Issue 3, September 2014, Pages: 639–648, H. Schelleman, X. Han, C. M. Brensinger, S. K. Quinney, W. B. Bilker, D. A. Flockhart, L. Li and Sean Hennessy

    Version of Record online : 21 AUG 2014, DOI: 10.1111/bcp.12353

  14. Risk of acute coronary events associated with glyburide compared with gliclazide use in patients with type 2 diabetes: a nested case–control study

    Diabetes, Obesity and Metabolism

    Volume 16, Issue 1, January 2014, Pages: 22–29, A. S. Abdelmoneim, D. T. Eurich, J. M. Gamble, J. A. Johnson, J. M. Seubert, W. Qiu and S. H. Simpson

    Version of Record online : 19 JUL 2013, DOI: 10.1111/dom.12173

  15. Nateglinide provides tighter glycaemic control than glyburide in patients with Type 2 diabetes with prevalent postprandial hyperglycaemia

    Diabetic Medicine

    Volume 28, Issue 5, May 2011, Pages: 560–566, A. Bellomo Damato, G. Stefanelli, L. Laviola, R. Giorgino and F. Giorgino

    Version of Record online : 12 APR 2011, DOI: 10.1111/j.1464-5491.2010.03219.x

  16. You have free access to this content
    Pharmacology of human sulphonylurea receptor SUR1 and inward rectifier K+ channel Kir6.2 combination expressed in HEK-293 cells

    British Journal of Pharmacology

    Volume 129, Issue 7, April 2000, Pages: 1323–1332, Murali Gopalakrishnan, Eduardo J Molinari, Char-Chang Shieh, Lisa M Monteggia, Jean-Marc Roch, Kristi L Whiteaker, Victoria E S Scott, James P Sullivan and Jorge D Brioni

    Version of Record online : 2 FEB 2009, DOI: 10.1038/sj.bjp.0703181

  17. Metabolic profile of glyburide in human liver microsomes using LC-DAD-Q-TRAP-MS/MS

    Biomedical Chromatography

    Volume 27, Issue 5, May 2013, Pages: 575–582, Selvan Ravindran, Sudipta Basu, Santosh Kapil Kumar Gorti, Prashant Surve and Navya Sloka

    Version of Record online : 15 OCT 2012, DOI: 10.1002/bmc.2830

  18. Adverse cardiovascular events during treatment with glyburide (glibenclamide) or gliclazide in a high-risk population

    Diabetic Medicine

    Volume 29, Issue 12, December 2012, Pages: 1524–1528, D. N. Juurlink, T. Gomes, B. R. Shah and M. M. Mamdani

    Version of Record online : 14 NOV 2012, DOI: 10.1111/j.1464-5491.2012.03772.x

  19. Coadministration of Pioglitazone or Glyburide and Alogliptin: Pharmacokinetic Drug Interaction Assessment in Healthy Participants

    The Journal of Clinical Pharmacology

    Volume 49, Issue 10, October 2009, Pages: 1210–1219, Dr Aziz Karim, Dr Aziz Laurent, Dr Melvin Munsaka, Dr Elisabeth Wann, Ms Penny Fleck and Dr Qais Mekki

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270009338938

  20. Saxagliptin, a potent, selective inhibitor of DPP-4, does not alter the pharmacokinetics of three oral antidiabetic drugs (metformin, glyburide or pioglitazone) in healthy subjects

    Diabetes, Obesity and Metabolism

    Volume 13, Issue 7, July 2011, Pages: 604–614, C. G. Patel, D. Kornhauser, N. Vachharajani, B. Komoroski, E. Brenner, M. Handschuh del Corral, L. Li and D. W. Boulton

    Version of Record online : 24 MAY 2011, DOI: 10.1111/j.1463-1326.2011.01381.x